Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
CALL
Ross Stores
ROST
$76.4B
| $18.7M | 0.01% |
291,300
-106,000
| -27% | -$6.52M |
|
1052
CALL
NetApp
NTAP
$36.8B
| $18.7M | 0.01% |
522,600
+62,400
| +14% | +$1.9M |
|
1053
PUT
Crown Castle
CCI
$32.4B
| $18.7M | 0.01% |
198,200
-24,800
| -11% | -$2.39M |
|
|
P
1054
PUT
Everpure Inc
P
$34.4B
| $18.7M | 0.01% |
1,376,900
-91,700
| -6% | -$1.14M |
|
1055
Perrigo
PRGO
$1.99B
| $18.7M | 0.01% |
202,009
-336,024
| -62% | -$31M |
|
|
BERY
1056
CALL
DELISTED
Berry Global Group, Inc.
BERY
| $18.6M | 0.01% |
463,043
+362,637
| +361% | +$14.2M |
|
1057
PUT
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $18.6M | 0.01% |
125,200
+35,200
| +39% | +$5.13M |
|
1058
PUT
Archer Daniels Midland
ADM
$37.4B
| $18.6M | 0.01% |
441,800
+75,700
| +21% | +$3.27M |
|
1059
CALL
Jazz Pharmaceuticals
JAZZ
$17.2B
| $18.6M | 0.01% |
152,800
-123,100
| -45% | -$16.6M |
|
|
SKX
1060
DELISTED
Skechers
SKX
| $18.5M | 0.01% |
810,018
+433,441
| +115% | +$11M |
|
|
S
1061
CALL
DELISTED
Sprint Corporation
S
| $18.5M | 0.01% |
2,796,300
+622,900
| +29% | +$3.69M |
|
1062
PUT
Mercado Libre
MELI
$101B
| $18.5M | 0.01% |
100,200
+600
| +0.6% | +$99.5K |
|
|
BID
1063
PUT
DELISTED
Sotheby's
BID
| $18.5M | 0.01% |
485,700
-87,900
| -15% | -$3.11M |
|
1064
PUT
United Parks & Resorts
PRKS
$2.03B
| $18.5M | 0.01% |
1,369,300
-2,632,500
| -66% | -$36.1M |
|
|
TTM
1065
PUT
DELISTED
Tata Motors Limited
TTM
| $18.4M | 0.01% |
460,900
+6,800
| +1% | +$264K |
|
1066
CALL
iShares MSCI Japan ETF
EWJ
$22.6B
| $18.4M | 0.01% |
366,750
-93,825
| -20% | -$4.57M |
|
1067
PUT
Dollar Tree
DLTR
$25.6B
| $18.4M | 0.01% |
233,300
-126,700
| -35% | -$11.4M |
|
1068
PUT
Cencora
COR
$61.9B
| $18.4M | 0.01% |
227,400
-487,600
| -68% | -$41.8M |
|
1069
CALL
Microchip Technology
MCHP
$39.9B
| $18.4M | 0.01% |
590,600
-127,600
| -18% | -$3.71M |
|
|
FL
1070
PUT
DELISTED
Foot Locker
FL
| $18.3M | 0.01% |
270,800
-51,200
| -16% | -$3.19M |
|
1071
CALL
Albemarle
ALB
$16B
| $18.3M | 0.01% |
214,300
-35,100
| -14% | -$2.89M |
|
1072
CALL
CNX Resources
CNX
$5.33B
| $18.3M | 0.01% |
1,143,720
-213,600
| -16% | -$3.15M |
|
1073
CALL
Five Below
FIVE
$14.3B
| $18.3M | 0.01% |
453,300
-74,400
| -14% | -$3.44M |
|
1074
PUT
Intuit
INTU
$98.5B
| $18.2M | 0.01% |
165,800
+75,700
| +84% | +$8.47M |
|
|
BID
1075
CALL
DELISTED
Sotheby's
BID
| $18.2M | 0.01% |
479,000
+56,900
| +13% | +$2.01M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.